信澳健康中国混合A(003291)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-165,962,365.81 |
-148,693,192.33 |
-558,908,914.25 |
-58,931,439.37 |
利息合计 |
1,664,690.51 |
1,181,695.42 |
5,540,933.00 |
3,264,427.33 |
其中:存款利息收入 |
661,981.87 |
297,586.19 |
1,393,508.96 |
733,861.96 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
1,002,708.64 |
884,109.23 |
4,147,424.04 |
2,530,565.37 |
投资收益合计 |
-219,483,169.72 |
-132,991,067.59 |
-366,852,264.66 |
-80,637,339.77 |
其中:股票投资收益 |
-236,090,777.85 |
-145,479,573.19 |
-401,556,494.60 |
-110,530,651.98 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
- |
- |
2,545,549.96 |
529,474.80 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
16,607,608.13 |
12,488,505.60 |
32,158,679.98 |
29,363,837.41 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
51,215,312.32 |
-17,205,325.10 |
-203,451,223.31 |
14,506,589.13 |
其他收入 |
640,801.08 |
321,504.94 |
5,853,640.72 |
3,934,883.94 |
费用 |
19,270,810.93 |
11,425,634.93 |
67,266,948.32 |
39,943,032.52 |
管理人报酬 |
14,275,611.27 |
8,438,006.80 |
47,812,541.97 |
28,145,831.39 |
基金托管费 |
2,379,268.45 |
1,406,334.44 |
7,968,757.03 |
4,690,971.93 |
销售服务费 |
2,387,761.21 |
1,452,580.31 |
11,227,074.04 |
6,985,250.97 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
228,170.00 |
128,713.38 |
258,572.49 |
120,976.14 |
利润总额 |
-185,233,176.74 |
-160,118,827.26 |
-626,175,862.57 |
-98,874,471.89 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年